rs34004825

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020971.3(SPTBN4):​c.-15-61G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,451,080 control chromosomes in the GnomAD database, including 14,879 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2531 hom., cov: 31)
Exomes 𝑓: 0.13 ( 12348 hom. )

Consequence

SPTBN4
NM_020971.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.65

Publications

3 publications found
Variant links:
Genes affected
SPTBN4 (HGNC:14896): (spectrin beta, non-erythrocytic 4) Spectrin is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton, and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. It is composed of two antiparallel dimers of alpha- and beta- subunits. This gene is one member of a family of beta-spectrin genes. The encoded protein localizes to the nuclear matrix, PML nuclear bodies, and cytoplasmic vesicles. A highly similar gene in the mouse is required for localization of specific membrane proteins in polarized regions of neurons. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SPTBN4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with hypotonia, neuropathy, and deafness
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Illumina, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 19-40472546-G-A is Benign according to our data. Variant chr19-40472546-G-A is described in ClinVar as Benign. ClinVar VariationId is 1260689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.268 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020971.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN4
NM_020971.3
MANE Select
c.-15-61G>A
intron
N/ANP_066022.2Q9H254-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN4
ENST00000598249.6
TSL:1 MANE Select
c.-15-61G>A
intron
N/AENSP00000469242.1Q9H254-1
SPTBN4
ENST00000352632.7
TSL:5
c.-15-61G>A
intron
N/AENSP00000263373.2Q9H254-1
SPTBN4
ENST00000595535.5
TSL:5
c.-15-61G>A
intron
N/AENSP00000470693.1M0QZQ3

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
25542
AN:
152026
Hom.:
2531
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.236
Gnomad NFE
AF:
0.129
Gnomad OTH
AF:
0.175
GnomAD4 exome
AF:
0.134
AC:
174063
AN:
1298936
Hom.:
12348
AF XY:
0.134
AC XY:
85369
AN XY:
634788
show subpopulations
African (AFR)
AF:
0.281
AC:
8254
AN:
29322
American (AMR)
AF:
0.0862
AC:
2314
AN:
26846
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
4519
AN:
19966
East Asian (EAS)
AF:
0.127
AC:
4628
AN:
36362
South Asian (SAS)
AF:
0.149
AC:
10158
AN:
68346
European-Finnish (FIN)
AF:
0.109
AC:
5192
AN:
47454
Middle Eastern (MID)
AF:
0.245
AC:
1290
AN:
5256
European-Non Finnish (NFE)
AF:
0.128
AC:
129411
AN:
1011592
Other (OTH)
AF:
0.154
AC:
8297
AN:
53792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
7224
14449
21673
28898
36122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5052
10104
15156
20208
25260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25553
AN:
152144
Hom.:
2531
Cov.:
31
AF XY:
0.166
AC XY:
12354
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.272
AC:
11289
AN:
41494
American (AMR)
AF:
0.111
AC:
1693
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
759
AN:
3472
East Asian (EAS)
AF:
0.151
AC:
784
AN:
5182
South Asian (SAS)
AF:
0.145
AC:
699
AN:
4828
European-Finnish (FIN)
AF:
0.104
AC:
1102
AN:
10612
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.129
AC:
8761
AN:
67988
Other (OTH)
AF:
0.172
AC:
364
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1084
2169
3253
4338
5422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.128
Hom.:
658
Bravo
AF:
0.173
Asia WGS
AF:
0.150
AC:
523
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.6
DANN
Benign
0.83
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34004825; hg19: chr19-40978453; API